Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

Transient effect of anti-CD20 therapy in a child with 22q11.2 deletion syndrome and severe steroid refractory cytopenias: a case report.

Soldatou A, Anastassiou T, Vougiouka O, Goussetis E, Kossiva L.

J Pediatr Hematol Oncol. 2013 May;35(4):311-4. doi: 10.1097/MPH.0b013e31828be602.

PMID:
23612383
[PubMed - indexed for MEDLINE]
2.

Rituximab in steroid refractory autoimmune hemolytic anemia.

Gupta N, Sharma S, Seth T, Mishra P, Mahapatra M, Kumar S, Kapoor R, Agarwal N.

Indian J Pediatr. 2012 Jun;79(6):803-5. doi: 10.1007/s12098-011-0544-4. Epub 2011 Aug 10.

PMID:
21830023
[PubMed - indexed for MEDLINE]
3.

Autoimmune cytopenias in the 22q11.2 deletion syndrome.

Davies JK, Telfer P, Cavenagh JD, Foot N, Neat M.

Clin Lab Haematol. 2003 Jun;25(3):195-7.

PMID:
12755799
[PubMed - indexed for MEDLINE]
4.

Adult Evans syndrome: complete hematologic recovery with steroids and rituximab: a case report.

Santiago-Ríos KJ, Reyes O, Cruz A, Rodríguez-Pabón N, Cáceres W.

Bol Asoc Med P R. 2010 Apr-Jun;102(2):33-6.

PMID:
20939201
[PubMed - indexed for MEDLINE]
5.

Rituximab for the treatment of post-bone marrow transplantation refractory hemolytic anemia in a child with Omenn's syndrome.

Silvana B, Antonella LM, Basilia P, Trombetta D, Saija A, Salpietro C.

Pediatr Transplant. 2007 Aug;11(5):552-6.

PMID:
17631027
[PubMed - indexed for MEDLINE]
6.
7.

Successful treatment of refractory donor lymphocyte infusion-induced immune-mediated pancytopenia with rituximab.

Kato I, Umeda K, Awaya T, Yui Y, Niwa A, Fujino H, Matsubara H, Watanabe K, Heike T, Adachi N, Endo F, Mizukami T, Nunoi H, Nakahata T, Adachi S.

Pediatr Blood Cancer. 2010 Feb;54(2):329-31. doi: 10.1002/pbc.22280.

PMID:
19890900
[PubMed - indexed for MEDLINE]
8.

Successful treatment of refractory autoimmune hepatitis with rituximab.

D'Agostino D, Costaguta A, Álvarez F.

Pediatrics. 2013 Aug;132(2):e526-30. doi: 10.1542/peds.2011-1900. Epub 2013 Jul 1.

PMID:
23821693
[PubMed - indexed for MEDLINE]
Free Article
9.

[Recurrent infections in an ITP patient treated with rituximab].

Rosenberg-Bezalel S, Asher I, Sthoeger Z.

Harefuah. 2012 Nov;151(11):617-9, 655. Hebrew.

PMID:
23367730
[PubMed - indexed for MEDLINE]
10.

Rituximab for the treatment of autoimmune cytopenias in children with immune deficiency.

Kim JJ, Thrasher AJ, Jones AM, Davies EG, Cale CM.

Br J Haematol. 2007 Jul;138(1):94-6. Epub 2007 May 11.

PMID:
17498197
[PubMed - indexed for MEDLINE]
11.

Successful treatment of refractory autoimmune haemolytic anaemia in a post-unrelated bone marrow transplant paediatric patient with rituximab.

Hongeng S, Tardtong P, Worapongpaiboon S, Ungkanont A, Jootar S.

Bone Marrow Transplant. 2002 May;29(10):871-2.

PMID:
12058238
[PubMed - indexed for MEDLINE]
Free Article
12.

Clinical assessment and management of cytopenias in lupus patients.

Levine AB, Erkan D.

Curr Rheumatol Rep. 2011 Aug;13(4):291-9. doi: 10.1007/s11926-011-0179-5. Review.

PMID:
21503695
[PubMed - indexed for MEDLINE]
13.

Severe refractory autoimmune hemolytic anemia with both warm and cold autoantibodies that responded completely to a single cycle of rituximab: a case report.

Gupta S, Szerszen A, Nakhl F, Varma S, Gottesman A, Forte F, Dhar M.

J Med Case Rep. 2011 Apr 19;5:156. doi: 10.1186/1752-1947-5-156.

PMID:
21504611
[PubMed]
Free PMC Article
14.

Rituximab.

Borker A, Choudhary N.

Indian Pediatr. 2011 Aug;48(8):627-32. Review.

PMID:
21918268
[PubMed - indexed for MEDLINE]
15.

Successful treatment of refractory autoimmune hemolytic anemia with monthly rituximab following nonmyeloablative stem cell transplantation for sickle cell disease.

Raj A, Bertolone S, Cheerva A.

J Pediatr Hematol Oncol. 2004 May;26(5):312-4.

PMID:
15111785
[PubMed - indexed for MEDLINE]
16.

Auto-immune pancytopenia in a child with DiGeorge syndrome.

Bruno B, Barbier C, Lambilliotte A, Rey C, Turck D.

Eur J Pediatr. 2002 Jul;161(7):390-2. Epub 2002 Jun 13.

PMID:
12111192
[PubMed - indexed for MEDLINE]
17.

Brucellosis-induced autoimmune hemolytic anemia treated with rituximab.

Bourantas LK, Pappas G, Kapsali E, Gougopoulou D, Papamichail D, Bourantas KL.

Ann Pharmacother. 2010 Oct;44(10):1677-80. doi: 10.1345/aph.1P249. Epub 2010 Sep 7.

PMID:
20823278
[PubMed - indexed for MEDLINE]
18.

Successful treatment with rituximab for acute refractory thrombotic thrombocytopenic purpura related to acquired ADAMTS13 deficiency: a pediatric report and literature review.

Harambat J, Lamireau D, Delmas Y, Ryman A, Llanas B, Brissaud O.

Pediatr Crit Care Med. 2011 Mar;12(2):e90-3. doi: 10.1097/PCC.0b013e3181e89f8f.

PMID:
20625343
[PubMed - indexed for MEDLINE]
19.

Fatal autoimmune pancytopenia following bone marrow transplantation for aplastic anaemia.

De Lord C, Marsh JC, Smith JG, Singer CR, Gordon-Smith EC.

Bone Marrow Transplant. 1996 Jul;18(1):237-9.

PMID:
8832026
[PubMed - indexed for MEDLINE]
20.

Long-term follow-up after rituximab for steroid-dependent idiopathic nephrotic syndrome.

Kemper MJ, Gellermann J, Habbig S, Krmar RT, Dittrich K, Jungraithmayr T, Pape L, Patzer L, Billing H, Weber L, Pohl M, Rosenthal K, Rosahl A, Mueller-Wiefel DE, Dötsch J.

Nephrol Dial Transplant. 2012 May;27(5):1910-5. doi: 10.1093/ndt/gfr548. Epub 2011 Nov 9.

PMID:
22076431
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk